You are here

Actelion re-enters transaction talks with Johnson & Johnson

Friday, December 23, 2016 - 05:50

40892951 - 16_12_2016 - ACTELION-M-A_.jpg
Swiss biotech company Actelion has turned back to prospective bidder Johnson & Johnson (J&J) for exclusive talks about a "strategic transaction", in an about-turn that appears to sideline rival suitor Sanofi.

Frankfurt

SWISS biotech company Actelion has turned back to prospective bidder Johnson & Johnson (J&J) for exclusive talks about a "strategic transaction", in an about-turn that appears to sideline rival suitor Sanofi.

Actelion said in a brief statement on Wednesday that it

sentifi.com

Market voices on:

Nespresso
Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at btsub.sg/btdeal

Powered by GET.comGetCom